For personal use. Only reproduce with permission from The Lancet. MEDICINE Ministers face demands from the organisation's parliamentary assembly for legal sanctions for medical staff involved in illegal transplantations.
The assembly complains of "loopholes" in national laws, due to lack of clarity on criminal responsibility.
A report from the assembly's health committee also calls on governments to deny medical insurance reimbursement for illegal transplantations abroadand to deny national health insurance payments for follow-up care for such operations.
However, the report, entitled Trafficking in organs in Europe (see http://www.coe. int) does not say how after care could be withheld. A position made more difficult given that the conference host, Norway's health minister Dagfinn Høybråten said in his opening speech that health services were obliged to "offer medical help for those in need, whatever the cause of need".
Due to be debated at the assembly's June 23-27 plenary in Strasbourg, the report points to "extremely well organised and extremely mobile" trafficking networks operating in Bulgaria, Georgia, Moldova, Romania, Russia, and Ukraine-all member states of the CoE.
The report estimates that there are 120 000 patients on chronic dialysis treatment and nearly 40 000 patients awaiting a kidney transplant in western Europe alone. The waiting time for transplantation, about 3 years at present, could be 10 years by 2010. Currently, 15-30% of patients die while waiting for a transplantation.
The committee's description of trafficking as "a regional problem" in eastern Europe drew protests from Bulgaria's deputy health minister Petko Salchev, who saw the report as a slur on his country.
The criticisms were brushed aside by the Icelandic parliamentarian who chairs the committee. Lara Margaret Ragnarsdottir, a guest speaker at the ministers' conference, insisted: "Governments have to assume responsibility to deal openly with this problem."
However, she acknowledged that trafficking in organs is "demand driven" and such crime should not remain the sole responsibility of the so-called donor countries in eastern Europe.
Ragnarsdottir voiced concern about "recent trends in some western European countries [the report mentions Germany and Switzerland] towards less restrictive laws would allow greater scope for unrelated, living donation and open possibilities for abuse".
Ragnarsdottir added that "criminal responsibility in organ trafficking is rarely clearly stated in national criminal codes".
She argued that medical staff who encourage and provide information on "transplant tourism" should also be liable in law, as should medical staff involved in follow-up care of patients who have purchased organs-if they fail to alert their authorities.
Demand for transplantations was just one aspect of a central theme of the conference: described by a Hungarian speaker as "the clash between the technically possible and the economically affordable".
Advance publicity had suggested that severe acute respiratory syndrome (SARS) and the threat of bioterrorism would be discussed. In the event, these topics were largely disregarded. SARS was recognised in the conference's final declaration as "only the most recent" illustration of the need for international cooperation on health issues.
The absence of the UK's health minister Alan Milburn became clear on news of his resignation (see p 2138).
It was left to host minister Høybråten to offer new ideas from Norway, a nation viewed as a testbed for health reforms.
European health ministers that have been mandated to push through health reforms using private sector investment, will draw encouragement from Høybråten's report that such reorganisation in Norway has achieved a 52% reduction in waiting times for elective surgery.
The reforms involved reallocating the facilities of 19 previously autonomous county hospital systems to five regional groupings. Although hospitals remain in public ownership, their management-operating on lines similar to those proposed for Britain's foundation hospitals-have greater freedom to follow commercial practice and to contract loans.
Høybråten has more reforms in the pipeline, aimed at reducing pressure on health-care budgets. These included a California-type ban on smoking in bars and restaurants.
Another reform, still under discussion in Norway, involves changing prescribing practices. Currently, if a physician prescribes a "blue prescription", based on the colour of the slip, the patient is entitled to full reimbursement-and the doctor receives a state fee.
Høybråten hopes to introduce an alternative "green prescription" where a change in lifestyle might be more beneficial to the patient than long-term treatment, as in the case of high blood pressure or diabetes.
Doctors would receive slightly higher fees if they agree to prescribe such change in regime and then supervise the patient's efforts to lose weight, change their diet, or give up smoking.
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